Navigation Links
Canadian researchers lead groundbreaking discovery in deadly childhood cancer
Date:12/11/2013

This news release is available in French.

MONTREAL, December 11th, 2013 A new study by Canadian researchers may pave the way for more effective treatment of an aggressive and deadly type of brain tumour, known as ETMR/ETANTR. The tumour, which is seen only in children under four, is almost always fatal, despite aggressive treatment. The study proposes a new model for how this brain tumour develops and suggests possible targets to investigate for novel therapies. These findings, recently published in Nature Genetics, also shed new light on the complex process of early brain development. The study was led by the Research Institute of the McGill University Health Centre (RI-MUHC), the McGill University and Genome Quebec Innovation Centre, and The Hospital for Sick Children (SickKids), and funded by the Cancer Research Society.

"We undertook this study because we wanted to learn what was driving the growth of these tumours and how best to treat them," says the study's co-principal investigator, Dr. Nada Jabado, hemato-oncologist at the Montreal Children's Hospital of the MUHC and an associate professor in the Department of Pediatrics at McGill University. "This is a very aggressive disease with poor outcomes for patients; we urgently need better treatments for these kids, and this study, which helps us better understand what happens in this tumour, moves us a little closer to that target."

"Our recent collaborations with Dr. Jabado's and Dr. Majewski's labs and other colleagues have provided opportunities to take our initial discovery of this entity closer to finding innovative treatments for this disease, which we believe is an important, yet under-recognized, infantile brain tumour, " says co-principal investigator Dr. Annie Huang, a brain tumour sp
'/>"/>

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-934-1934 x71381
McGill University Health Centre
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
2. Supplement use predicts folate status in Canadian women
3. Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles
4. Ducks Unlimited Canada and Canadian Light Source partnership to shed light on wetlands
5. 6th Annual Canadian Neuroscience Meeting, Vancouver, May 20-23, 2012
6. Advanced Photon Source and Canadian Light Source strengthen ties
7. Concern about plans to close unique Canadian environmental project
8. Canadian homes a kill zone for up to 22 million birds a year
9. Climate-smart strategies proposed for spectacular US-Canadian landscape
10. A European invader outcompetes Canadian plants even outside its usual temperature range
11. Canadians support interventions to reduce dietary salt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... The week-long discussions and decisions of the Nomenclature Section ... Melbourne, Australia in July 2011. This meeting is held ... premier experts on the rules for naming algae, fungi ... rule book for naming the organisms they study. This ... Code of Nomenclature for algae, fungi, and plants, which ...
(Date:8/31/2014)... bacteria C. diff , that causes diarrhoea, temperature ... at the University of Leicester. , Using a mass ... possible to identify the unique ,smell, of C. ... the condition., What is more, the Leicester team say ... the disease simply from their smell a chemical ...
(Date:8/31/2014)... the last 19 years reveals that fresh water from melting ... to rise by 2cm more than the global average of ... rapid rise in sea-level by studying satellite scans of a ... , The melting of the Antarctic ice sheet and ... of around 350 gigatonnes of freshwater to the surrounding ocean. ...
Breaking Biology News(10 mins):Week-long meeting on naming algae, fungi, and plants recorded for posterity 2Scientists develop 'electronic nose' for rapid detection of C. diff infection 2
... been inspiring debate across the scientific community since the ... wider discussion about open access publishing has advanced to ... its first few articles (please see http://f1000research.com/articles ). ... further articles will be published on the current consultation ...
... have long known that the body rids itself of excess ... liver and excreting them through the liver,s bile. However, a ... 22 in PLoS ONE suggests that when this ... A molecule sequesters only that mineral and routes it from ...
... new genetic mutation that causes familial amyotrophic lateral sclerosis ... Gehrig,s Disease, has been identified by a team of ... Medical School (UMMS). Mutations to the profilin (PFN1) gene, ... nerve cell axons, is estimated to account for one ...
Cached Biology News:First articles now live on F1000 Research 2First articles now live on F1000 Research 3Copper's previously unknown exit strategy 2Copper's previously unknown exit strategy 3UMMS researchers isolate gene mutations in patients with inherited amyotrophic lateral sclerosis 2UMMS researchers isolate gene mutations in patients with inherited amyotrophic lateral sclerosis 3
(Date:8/31/2014)... N.J. , Aug. 31, 2014 Wockhardt ... Drug Discovery program in Anti-Infective research when two of ... coveted Qualified Infectious Disease Product (QIDP) status from U.S. ... to drugs which act against pathogens which have a ... are identified by Centre for Disease Control (a top ...
(Date:8/31/2014)... August 31, 2014 2014 ... is a professional and in-depth research report ... basic Polyacrylamide information, including Polyacrylamide definition, classification, ... as industry overview. This research covers the ... well as global industry analysis covering macroeconomic ...
(Date:8/30/2014)... The Global and China Electrical Insulating ... on the current state of the Electrical Insulating ... report provides a basic overview of the industry, ... market analysis and Chinese domestic market analysis are ... and competitive landscape of the market. A comparison ...
(Date:8/29/2014)... of the most promising technologies for future quantum circuits ... instead of electrons. First, it is necessary to be ... control their direction. Researchers around the world have made ... now scientists at the Niels Bohr Institute have succeeded ... at a time and in a particular direction. The ...
Breaking Biology Technology:U.S. FDA Grants QIDP Status for Wockhardt Anti-Infective Drug Discovery Program 2U.S. FDA Grants QIDP Status for Wockhardt Anti-Infective Drug Discovery Program 3International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 2International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 3Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 2Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 3Breakthrough in light sources for new quantum technology 2
... 11 AtriCure, Inc.,(Nasdaq: ATRC ), a ... surgical,ablation products, today announced that the first patient ... Richard Kaplon, a,well-known cardiac surgeon, performed the procedure ... purpose of the ABLATE clinical trial is to ...
... 11, Bayer HealthCare affiliate MEDRAD, Inc., Warrendale, PA ... ), announced today that,they have entered into a ... Possis Medical in a cash tender offer for ... of approximately US-Dollar 361,million. The offer price represents ...
... Ltd. announced that the,quantitative analysis of Replikin Count(TM) ... H5N1 cycle is over. Sporadic outbreaks may,continue, but ... expected to subside - until the next rapid ... begins., 140,000 virus protein sequences were analyzed ...
Cached Biology Technology:AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation 2AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation 4Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 2Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 3Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 4Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 5Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 6FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over 2